BIOLOGICAL EFFECTS OF PERTUSSIS TOXIN B-OLIGOMER
BIOLOGICAL EFFECTS OF PERTUSSIS TOXIN B-OLIGOMER
批准号:
3146145
负责人:
ERIK L HEWLETT
金额:
$26.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-01 至 1995-04-30
关键词:
ADP ribosylation CD3 molecule SDS polyacrylamide gel electrophoresis T cell receptor T lymphocyte affinity labeling calcium flux cyclic AMP cyclic GMP cytotoxic T lymphocyte glycolipids glycoproteins immune tolerance /unresponsiveness immunoprecipitation laboratory mouse lymphocyte proliferation monoclonal antibody neoplastic cell culture for noncancer research neurons pertussis toxin phosphatidylinositols phospholipase A2 phospholipase C platelet activation prostaglandins protein kinase C protein structure function protein tyrosine kinase receptor binding receptor expression second messengers site directed mutagenesis thin layer chromatography tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Pertussis is a major cause of childhood morbidity in the developing world
and as a result of concerns about pertussis vaccine reactogenicity, has
increased in incidence in many areas of the developed world. Pertussis
toxin (PT), a major virulence factor of Bordetella pertussis, elicits a
variety of effects including lymphocytosis, sensitization to histamine, and
enhancement of insulin secretion. Intriguingly, the B or binding component
of PT (B-oligomer), which delivers its active portion to target cells, has
biological effects of its own, namely calcium mobilization followed by
lymphocyte proliferation and platelet aggregation. These actions, which
are poorly understood, are independent of the ADP-ribosylation of G-
proteins by which PT has the majority of its known effects. Acquisition of
more information is important because many acellular pertussis vaccines
contain PT in which holotoxin activities are eliminated, but B-oligomer
effects are present or enhanced. In this proposal, different preparations
of B-oligomer and holotoxin will be evaluated for potency in eliciting B-
oligomer effects (lymphocyte proliferation and platelet activation). The
second messenger systems involved will be explored and a screen of other
cell types will be made for responses to B-oligomer. The receptor for B-
oligomer action will be identified and the structural requirements for B-
oligomer to elicit its effects will be studied with toxins containing
mutations at specific sites. Finally, the relationship between B-oligomer
mobilization of calcium and the subsequent intoxication of a target cell by
ADP-ribosylation will be investigated. The resultant data will provide a
perspective on using B-oligomer as a research tool and will guide its use
as an antigen in acellular pertussis vaccine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
11th International Symposium on Bordetella
-
批准号:9053803
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2016
-
负责人:ERIK L HEWLETT
-
依托单位:
Integrated analysis of cellular responses to toxins from clostridium difficile
-
批准号:8233381
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2011
-
负责人:ERIK L HEWLETT
-
依托单位:
Bordetella cyclase toxin: effects on leukocytes and respiratory epithelial cells
-
批准号:7846692
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2009
-
负责人:ERIK L HEWLETT
-
依托单位:
Integrated analysis of cellular responses to toxins from clostridium difficile
-
批准号:7670083
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2009
-
负责人:ERIK L HEWLETT
-
依托单位:
Anthrax
-
批准号:7678783
-
项目类别:
-
资助金额:$51.16万
-
财政年份:2008
-
负责人:ERIK L HEWLETT
-
依托单位:
8th International Symposium - Saga of the Genus Bordetella, 1906-2006
-
批准号:7230901
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2006
-
负责人:ERIK L HEWLETT
-
依托单位:
Seventh International Symposium on Pertussis
-
批准号:6557658
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2002
-
负责人:ERIK L HEWLETT
-
依托单位:
1998 GORDON CONFERENCE-MICROBIAL TOXINS & PATH
-
批准号:2670026
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1998
-
负责人:ERIK L HEWLETT
-
依托单位:
General Clinical Research Center
-
批准号:7591148
-
项目类别:
-
资助金额:$478.77万
-
财政年份:1997
-
负责人:ERIK L HEWLETT
-
依托单位:
General Clinical Research Center
-
批准号:7821393
-
项目类别:
-
资助金额:$493.14万
-
财政年份:1997
-
负责人:ERIK L HEWLETT
-
依托单位:
General Clinical Research Center
-
批准号:7229536
-
项目类别:
-
资助金额:$460.5万
-
财政年份:1997
-
负责人:ERIK L HEWLETT
-
依托单位:
General Clinical Research Center
-
批准号:7408527
-
项目类别:
-
资助金额:$464.83万
-
财政年份:1997
-
负责人:ERIK L HEWLETT
-
依托单位:
BIOLOGICAL EFFECTS OF PERTUSSIS TOXIN B-OLIGOMER
-
批准号:2066121
-
项目类别:
-
资助金额:$27.58万
-
财政年份:1991
-
负责人:ERIK L HEWLETT
-
依托单位:
BIOLOGICAL EFFECTS OF PERTUSSIS TOXIN B-OLIGOMER
-
批准号:3146144
-
项目类别:
-
资助金额:$25.57万
-
财政年份:1991
-
负责人:ERIK L HEWLETT
-
依托单位:
BIOLOGICAL EFFECTS OF PERTUSSIS TOXIN B-OLIGOMER
-
批准号:3146146
-
项目类别:
-
资助金额:$27.43万
-
财政年份:1991
-
负责人:ERIK L HEWLETT
-
依托单位:
DIABETES ENDOCRINOLOGY RESEARCH CENTER
-
批准号:3102135
-
项目类别:
-
资助金额:$39.2万
-
财政年份:1987
-
负责人:ERIK L HEWLETT
-
依托单位:
BORDETELLA CYCLASE-STRUCTURE AND BIOLOGICAL ACTIVITIES
-
批准号:6843723
-
项目类别:
-
资助金额:$37.0万
-
财政年份:1980
-
负责人:ERIK L HEWLETT
-
依托单位:
BORDETELLA CYCLASE: STRUCTURE AND BIOLOGICAL ACTIVITY
-
批准号:3127627
-
项目类别:
-
资助金额:$21.19万
-
财政年份:1980
-
负责人:ERIK L HEWLETT
-
依托单位:
BORDETELLA CYCLASE: STRUCTURE AND BIOLOGICAL ACTIVITY
-
批准号:3127628
-
项目类别:
-
资助金额:$22.55万
-
财政年份:1980
-
负责人:ERIK L HEWLETT
-
依托单位:
BORDETELLA CYCLASE--STRUCTURE AND BIOLOGICAL ACTIVITIES
-
批准号:2607735
-
项目类别:
-
资助金额:$30.51万
-
财政年份:1980
-
负责人:ERIK L HEWLETT
-
依托单位:
海外基金